166 related articles for article (PubMed ID: 33812985)
21. The impact of oncogenic RAS on redox balance and implications for cancer development.
Lim JKM; Leprivier G
Cell Death Dis; 2019 Dec; 10(12):955. PubMed ID: 31852884
[TBL] [Abstract][Full Text] [Related]
22. SUMOylation in carcinogenesis.
Bettermann K; Benesch M; Weis S; Haybaeck J
Cancer Lett; 2012 Mar; 316(2):113-25. PubMed ID: 22138131
[TBL] [Abstract][Full Text] [Related]
23. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
24. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
Huang L; Counter CM
PLoS One; 2015; 10(4):e0123918. PubMed ID: 25902334
[TBL] [Abstract][Full Text] [Related]
25. An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.
Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Parinov S; Gong Z
Dis Model Mech; 2012 Jan; 5(1):63-72. PubMed ID: 21903676
[TBL] [Abstract][Full Text] [Related]
26. RAS-mediated oncogenic signaling pathways in human malignancies.
Khan AQ; Kuttikrishnan S; Siveen KS; Prabhu KS; Shanmugakonar M; Al-Naemi HA; Haris M; Dermime S; Uddin S
Semin Cancer Biol; 2019 Feb; 54():1-13. PubMed ID: 29524560
[TBL] [Abstract][Full Text] [Related]
27. Blockade of mutant RAS oncogenic signaling with a special emphasis on KRAS.
Roskoski R
Pharmacol Res; 2021 Oct; 172():105806. PubMed ID: 34450320
[TBL] [Abstract][Full Text] [Related]
28. Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants.
Alcantara KMM; Malapit JRP; Yu RTD; Garrido JAMG; Rigor JPT; Angeles AKJ; Cutiongco-de la Paz EM; Garcia RL
Cells; 2019 Dec; 8(12):. PubMed ID: 31816869
[TBL] [Abstract][Full Text] [Related]
29. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
Lee SK; Hwang JH; Choi KY
Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
[TBL] [Abstract][Full Text] [Related]
30. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
31. The renewed battle against RAS-mutant cancers.
Zhang F; Cheong JK
Cell Mol Life Sci; 2016 May; 73(9):1845-58. PubMed ID: 26892781
[TBL] [Abstract][Full Text] [Related]
32. Bach1 is critical for the transformation of mouse embryonic fibroblasts by Ras(V12) and maintains ERK signaling.
Nakanome A; Brydun A; Matsumoto M; Ota K; Funayama R; Nakayama K; Ono M; Shiga K; Kobayashi T; Igarashi K
Oncogene; 2013 Jul; 32(27):3231-45. PubMed ID: 22847612
[TBL] [Abstract][Full Text] [Related]
33. The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation.
Stewart S; Guan KL
J Biol Chem; 2000 Mar; 275(12):8854-62. PubMed ID: 10722731
[TBL] [Abstract][Full Text] [Related]
34. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo.
Sansom OJ; Meniel V; Wilkins JA; Cole AM; Oien KA; Marsh V; Jamieson TJ; Guerra C; Ashton GH; Barbacid M; Clarke AR
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14122-7. PubMed ID: 16959882
[TBL] [Abstract][Full Text] [Related]
35. Targeting the RAS-dependent chemoresistance: The Warburg connection.
Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
[TBL] [Abstract][Full Text] [Related]
36. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
Nussinov R; Tsai CJ; Jang H
Semin Cancer Biol; 2019 Feb; 54():114-120. PubMed ID: 29307569
[TBL] [Abstract][Full Text] [Related]
37. K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways.
Matsuo Y; Campbell PM; Brekken RA; Sung B; Ouellette MM; Fleming JB; Aggarwal BB; Der CJ; Guha S
Mol Cancer Res; 2009 Jun; 7(6):799-808. PubMed ID: 19509115
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
[TBL] [Abstract][Full Text] [Related]
39. Detection and Functional Analysis of SUMO-Modified MEK.
Kubota Y; Takekawa M
Methods Mol Biol; 2017; 1487():99-111. PubMed ID: 27924561
[TBL] [Abstract][Full Text] [Related]
40. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
